A Prospective Natural History Study of Lymphatic Anomalies
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT05731141
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 0 mo–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1200
- US sites recruiting
- 1
- Study start
- March 20, 2023
- Record last updated
- October 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Background
The lymphatic system is a network of vessels that carry a clear fluid called lymph through the body. Problems in the lymphatic system can cause pain, fluid buildup, and issues with immunity. There is much researchers do not understand about lymphatic anomalies. In this natural history study, they will collect data from a lot of people over a long time.
Objective
To better understand why lymphatic anomalies develop. The goal is to improve future treatments.
Eligibility
People aged 0 days and older with a suspected or confirmed lymphatic anomaly. Their unaffected parents or siblings aged 7 years or older are also needed.
Design
Participants may remain in the study indefinitely. Affected participants may be evaluated every 10 months to 2 years. Some participants will be seen over telemedicine. Others will be seen at the NIH Clinical Center for 2-5 days.
All participants will have a physical exam. They may provide specimens including blood, saliva, hair follicles, stool, skin, and other tissues. Samples may be used for genetic testing.
Participants may undergo other tests depending on their medical conditions. The NIH Clinical Center visit may include:
Heart tests include placing stickers on the chest to measure electrical activity and using sound waves to capture pictures of the heart.
A lung test measures the muscle strength in the chest. Participants will blow into a tube.
Photographs may be taken of participants faces and other features.
Imaging scans will take pictures of the inside of the body. One scan will measure bone density.
One type of scan tracks how lymph fluid moves through the body. Participants will be under anesthesia, and they will be injected with a dye.
Conditions: Lymphatic Diseases; Lymphatic Abnormalities
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
- INCLUSION CRITERIA:
Affected (Proband)
In order to be eligible to participate in this study, an individual must meet one of the following criteria as determined after review of medical history:
- Current or history of lymphatic anomaly or symptoms suggestive of a lymphatic disorder Or
- An ill-defined vascular anomaly that is suspected to have an abnormal lymphatic component Or
- A pathogenic, likely pathogenic, or VUS in a genetic disorder with a known lymphatic component Or
- Clinical diagnosis of a syndrome with a known lymphatic component
Unaffected (First Degree Relatives: Parents and Siblings)
Genetic variants underlying complex lymphatic anomalies can be passed down through parents or be new in a child (de novo). Inclusion of first-degree relatives will assist in genetic analysis to delineate whether the variant is inherited or de novo.
To be eligible to participate as a first degree relative in this study, an individual must be a first-degree family member of an affected participants
EXCLUSION CRITERIA
Affected Proband
An individual who meets any of the following criteria will be excluded from participation in this study after review of medical history, concomitant medication and allergy review, anthropometrics, and performance status:
-Any condition, in the opinion of the investigator, that would increase risk of participation or impair their ability to comply with protocol requirements.
Lymphatic anomalies that are definitively determined to be secondary by the principal investigator will be excluded from this study. For example, participants who develop a lymphedema after breast cancer surgery.
Unaffected (First Degree Relatives)
-Any condition, in the opinion of the investigator, that would increase risk of participation or impair their ability to comply with protocol requirements.
Recruiting US locations
National Institutes of Health Clinical Center
Bethesda, MD 20892
Site contact: NIH Clinical Center Office of Patient Recruitment (OPR) · 800-411-1222 · ccopr@nih.gov
Study contacts (from the official record)
- Andrea I Bowling, C.R.N.P. · (301) 451-3824 · nichd_lymphaticanoma@mail.nih.gov
- Sarah E Sheppard, M.D. · (240) 578-5047 · sarah.sheppard@nih.gov
Similar studies in Maryland
All healthy volunteers studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Johns Hopkins University
- Location
- Baltimore, MD
- Eligibility basics
- Ages 21–55